3 - 6 മാസത്തേക്കുള്ള മികച്ച മ്യൂച്വൽ ഫണ്ട്

Updated on August 26, 2026 , 112398 views

3 മുതൽ 6 മാസം വരെയുള്ള ചെറിയ കാലയളവിലേക്ക്, നിങ്ങൾക്ക് ഒന്നുകിൽ നിങ്ങളുടെ പണം പാർക്ക് ചെയ്യാംലിക്വിഡ് മ്യൂച്വൽ ഫണ്ടുകൾ അല്ലെങ്കിൽ അൾട്രാ ഷോർട്ട് ടേംകടം മ്യൂച്വൽ ഫണ്ട്. ദ്രാവകമ്യൂച്വൽ ഫണ്ടുകൾ സാധാരണയായി ഗവൺമെന്റ് സെക്യൂരിറ്റികളിലും 3 മാസം വരെയുള്ള നിക്ഷേപ സർട്ടിഫിക്കറ്റുകളിലും നിക്ഷേപിക്കുക.

എന്നിരുന്നാലും ഉയർന്ന റിട്ടേണുകൾക്കായി റിസ്ക് എടുക്കാൻ ഒരാൾ ഉത്സുകനാണെങ്കിൽ ചുവടെയുള്ള കുറച്ച് ഓപ്ഷനുകൾ നോക്കാം

3 മാസത്തെ മികച്ച 5 മ്യൂച്വൽ ഫണ്ടുകൾ

ഇവയുടെ ലിസ്റ്റ് ചുവടെയുണ്ട്മികച്ച മ്യൂച്വൽ ഫണ്ടുകൾ മൊത്തം ആസ്തി കഴിഞ്ഞു100 കോടി കൂടാതെ കഴിഞ്ഞ 3 മാസങ്ങളിൽ മികച്ച വരുമാനം നൽകി.

1. DSP World Gold Fund

"The primary investment objective of the Scheme is to seek capital appreciation by investing predominantly in units of MLIIF - WGF. The Scheme may, at the discretion of the Investment Manager, also invest in the units of other similar overseas mutual fund schemes, which may constitute a significant part of its corpus. The Scheme may also invest a certain portion of its corpus in money market securities and/or units of money market/liquid schemes of DSP Merrill Lynch Mutual Fund, in order to meet liquidity requirements from time to time. However, there is no assurance that the investment objective of the Scheme will be realized."

Research Highlights for DSP World Gold Fund

Bottom quartile AUM (₹1,441 Cr).
Established history (18+ yrs).
Rating: 3★ (upper mid).
Risk profile: High.
5Y return: 31.39% (top quartile).
3Y return: 61.12% (top quartile).
1Y return: 87.50% (top quartile).
Alpha: 2.59 (lower mid).
Sharpe: 1.14 (top quartile).
Information ratio: -0.56 (bottom quartile).
Higher exposure to Basic Materials vs peer median.
Higher exposure to Cash Equivalent (bond sector) vs peer median.
Equity-heavy allocation (~93%).
Largest holding BGF World Gold I2 (~67.0%).
Top-3 holdings concentration ~100.3%.

Below is the key information for DSP World Gold Fund

DSP World Gold Fund Growth
Launch Date	14 Sep 07
NAV (27 Aug 26)	₹67.0088 ↓ -0.51 (-0.76 %)
Net Assets (Cr)	₹1,441 on 31 Jul 26
Category	Equity - Global
AMC	DSP BlackRock Invmt Managers Pvt. Ltd.
Rating	☆☆☆
Risk	High
Expense Ratio	1.41
Sharpe Ratio	1.14
Information Ratio	-0.56
Alpha Ratio	2.59
Min Investment	1,000
Min SIP Investment	500
Exit Load	0-12 Months (1%),12 Months and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
31 Jul 21	₹10,000
31 Jul 22	₹7,373
31 Jul 23	₹9,366
31 Jul 24	₹11,150
31 Jul 25	₹16,504
31 Jul 26	₹26,355

DSP World Gold Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹657,502.
Net Profit of ₹357,502 Invest Now

Returns for DSP World Gold Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 27 Aug 26

Duration	Returns
1 Month	32.4%
3 Month	17.9%
6 Month	-4.4%
1 Year	87.5%
3 Year	61.1%
5 Year	31.4%
10 Year
15 Year
Since launch	10.6%

Historical performance (Yearly) on absolute basis

Year	Returns
2025	167.1%
2024	15.9%
2023	7%
2022	-7.7%
2021	-9%
2020	31.4%
2019	35.1%
2018	-10.7%
2017	-4%
2016	52.7%

Fund Manager information for DSP World Gold Fund

Name	Since	Tenure
Kaivalya Nadkarni	1 May 25	1.25 Yr.

Data below for DSP World Gold Fund as on 31 Jul 26

Equity Sector Allocation

Sector	Value
Basic Materials	92.85%

Asset Allocation

Asset Class	Value
Cash	5.2%
Equity	93.02%
Debt	0.01%
Other	1.77%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
BGF World Gold I2 Investment Fund \| -	67%	₹960 Cr	983,452 ↓ -21,591
VanEck Gold Miners ETF - \| GDX	29%	₹409 Cr	573,719
Treps / Reverse Repo Investments CBLO/Reverse Repo \| -	5%	₹67 Cr
Net Receivables/Payables Net Current Assets \| -	0%	-₹4 Cr

2. Motilal Oswal Focused 25 Fund

(Erstwhile Motilal Oswal MOSt Focused 25 Fund)

The investment objective of the Scheme is to achieve long term capital appreciation by investing in upto 25 companies with long term sustainable competitive advantage and growth potential. However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved.

Research Highlights for Motilal Oswal Focused 25 Fund

Bottom quartile AUM (₹1,693 Cr).
Established history (13+ yrs).
Rating: 3★ (lower mid).
Risk profile: Moderately High.
5Y return: 10.38% (bottom quartile).
3Y return: 14.39% (bottom quartile).
1Y return: 29.45% (upper mid).
Alpha: 12.26 (top quartile).
Sharpe: 0.61 (lower mid).
Information ratio: -0.07 (bottom quartile).
Top sector: Financial Services.
Top bond sector: Cash Equivalent.
Equity-heavy allocation (~94%).
Largest holding Rubicon Research Ltd (~4.4%).

Below is the key information for Motilal Oswal Focused 25 Fund

Motilal Oswal Focused 25 Fund Growth
Launch Date	7 May 13
NAV (28 Aug 26)	₹53.8804 ↑ 0.21 (0.40 %)
Net Assets (Cr)	₹1,693 on 31 Jul 26
Category	Equity - Focused
AMC	Motilal Oswal Asset Management Co. Ltd
Rating	☆☆☆
Risk	Moderately High
Expense Ratio	1.97
Sharpe Ratio	0.61
Information Ratio	-0.07
Alpha Ratio	12.26
Min Investment	5,000
Min SIP Investment	500
Exit Load	0-1 Years (1%),1 Years and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
31 Jul 21	₹10,000
31 Jul 22	₹10,120
31 Jul 23	₹11,523
31 Jul 24	₹15,422
31 Jul 25	₹13,725
31 Jul 26	₹15,997

Motilal Oswal Focused 25 Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹395,578.
Net Profit of ₹95,578 Invest Now

Returns for Motilal Oswal Focused 25 Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 27 Aug 26

Duration	Returns
1 Month	9.7%
3 Month	15.9%
6 Month	25.4%
1 Year	29.4%
3 Year	14.4%
5 Year	10.4%
10 Year
15 Year
Since launch	13.5%

Historical performance (Yearly) on absolute basis

Year	Returns
2025	-1.7%
2024	13.6%
2023	18.8%
2022	2%
2021	14.6%
2020	17.3%
2019	17.1%
2018	-4.2%
2017	32.2%
2016	2.8%

Fund Manager information for Motilal Oswal Focused 25 Fund

Name	Since	Tenure
Varun Sharma	14 Aug 25	0.96 Yr.
Swapnil Mayekar	18 Nov 25	0.7 Yr.
Ankit Agarwal	5 Aug 25	0.99 Yr.
Rakesh Shetty	22 Nov 22	3.69 Yr.
Atul Mehra	1 Oct 24	1.83 Yr.

Data below for Motilal Oswal Focused 25 Fund as on 31 Jul 26

Equity Sector Allocation

Sector	Value
Financial Services	24.62%
Industrials	23.13%
Consumer Cyclical	18.96%
Health Care	8.46%
Technology	7.86%
Communication Services	3.06%
Utility	2.93%
Basic Materials	2.66%

Asset Allocation

Asset Class	Value
Cash	6.44%
Equity	93.56%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
Rubicon Research Ltd (Healthcare) Equity, Since 30 Apr 26 \| RUBICON	4%	₹73 Cr	518,073 ↑ 13,036
AU Small Finance Bank Ltd (Financial Services) Equity, Since 31 Oct 25 \| 540611	4%	₹69 Cr	669,589 ↑ 23,881
Eternal Ltd (Consumer Cyclical) Equity, Since 31 Jan 26 \| ETERNAL	4%	₹69 Cr	2,592,637 ↑ 62,681
CG Power & Industrial Solutions Ltd (Industrials) Equity, Since 28 Feb 26 \| 500093	4%	₹67 Cr	707,583
Aditya Infotech Ltd (Industrials) Equity, Since 28 Feb 26 \| CPPLUS	4%	₹66 Cr	181,175 ↓ -80,000
ICICI Prudential Asset Management Co Ltd (Financial Services) Equity, Since 31 Jan 26 \| ICICIAMC	4%	₹66 Cr	197,893 ↑ 4,703
Apollo Hospitals Enterprise Ltd (Healthcare) Equity, Since 28 Feb 26 \| APOLLOHOSP	4%	₹66 Cr	75,565
PNB Housing Finance Ltd (Financial Services) Equity, Since 31 May 26 \| PNBHOUSING	4%	₹57 Cr	553,533 ↑ 70,874
Titan Co Ltd (Consumer Cyclical) Equity, Since 31 Oct 25 \| TITAN	4%	₹57 Cr	130,247 ↑ 3,709
Gabriel India Ltd (Consumer Cyclical) Equity, Since 31 Aug 25 \| GABRIEL	3%	₹56 Cr	455,227 ↓ -81,000

3. Motilal Oswal Midcap 30 Fund

(Erstwhile Motilal Oswal MOSt Focused Midcap 30 Fund)

The investment objective of the Scheme is to achieve long term capital appreciation by investing in a maximum of 30 quality mid-cap companies having long-term competitive advantages and potential for growth. However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved.

Research Highlights for Motilal Oswal Midcap 30 Fund

Highest AUM (₹40,036 Cr).
Established history (12+ yrs).
Rating: 3★ (bottom quartile).
Risk profile: Moderately High.
5Y return: 22.62% (upper mid).
3Y return: 20.98% (lower mid).
1Y return: 3.65% (bottom quartile).
Alpha: -9.71 (bottom quartile).
Sharpe: -0.24 (bottom quartile).
Information ratio: 0.06 (upper mid).
Higher exposure to Financial Services vs peer median.
Top bond sector: Cash Equivalent.
Equity-heavy allocation (~97%).
Largest holding One97 Communications Ltd (~7.3%).

Below is the key information for Motilal Oswal Midcap 30 Fund

Motilal Oswal Midcap 30 Fund Growth
Launch Date	24 Feb 14
NAV (28 Aug 26)	₹106.245 ↑ 0.05 (0.04 %)
Net Assets (Cr)	₹40,036 on 31 Jul 26
Category	Equity - Mid Cap
AMC	Motilal Oswal Asset Management Co. Ltd
Rating	☆☆☆
Risk	Moderately High
Expense Ratio	1.56
Sharpe Ratio	-0.24
Information Ratio	0.06
Alpha Ratio	-9.71
Min Investment	5,000
Min SIP Investment	500
Exit Load	0-1 Years (1%),1 Years and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
31 Jul 21	₹10,000
31 Jul 22	₹12,488
31 Jul 23	₹15,748
31 Jul 24	₹26,692
31 Jul 25	₹27,117
31 Jul 26	₹26,669

Motilal Oswal Midcap 30 Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹530,691.
Net Profit of ₹230,691 Invest Now

Returns for Motilal Oswal Midcap 30 Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 27 Aug 26

Duration	Returns
1 Month	6.8%
3 Month	13.9%
6 Month	19.3%
1 Year	3.7%
3 Year	21%
5 Year	22.6%
10 Year
15 Year
Since launch	20.8%

Historical performance (Yearly) on absolute basis

Year	Returns
2025	-12.1%
2024	57.1%
2023	41.7%
2022	10.7%
2021	55.8%
2020	9.3%
2019	9.7%
2018	-12.7%
2017	30.8%
2016	5.2%

Fund Manager information for Motilal Oswal Midcap 30 Fund

Name	Since	Tenure
Varun Sharma	21 Jan 26	0.53 Yr.
Swapnil Mayekar	18 Nov 25	0.7 Yr.
Ajay Khandelwal	1 Oct 24	1.83 Yr.
Ankit Agarwal	21 Jan 26	0.53 Yr.
Rakesh Shetty	22 Nov 22	3.69 Yr.

Data below for Motilal Oswal Midcap 30 Fund as on 31 Jul 26

Equity Sector Allocation

Sector	Value
Financial Services	31.53%
Technology	26.25%
Industrials	15.4%
Consumer Cyclical	14.49%
Real Estate	3.1%
Communication Services	2.97%
Health Care	2.8%
Consumer Defensive	0.57%

Asset Allocation

Asset Class	Value
Cash	2.89%
Equity	97.11%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
One97 Communications Ltd (Technology) Equity, Since 30 Sep 24 \| PAYTM	7%	₹2,751 Cr	24,100,476 ↑ 334,611
Kalyan Jewellers India Ltd (Consumer Cyclical) Equity, Since 29 Feb 24 \| KALYANKJIL	6%	₹2,375 Cr	61,413,395
Coforge Ltd (Technology) Equity, Since 31 Mar 23 \| COFORGE	6%	₹2,265 Cr	15,453,312 ↓ -250,000
Eternal Ltd (Consumer Cyclical) Equity, Since 31 Aug 25 \| ETERNAL	6%	₹2,233 Cr	84,386,866
KEI Industries Ltd (Industrials) Equity, Since 30 Nov 24 \| KEI	6%	₹2,101 Cr	3,870,834 ↓ -160,000
Aditya Birla Capital Ltd (Financial Services) Equity, Since 30 Jun 25 \| ABCAPITAL	5%	₹2,056 Cr	52,459,381
Persistent Systems Ltd (Technology) Equity, Since 31 Jan 23 \| PERSISTENT	5%	₹1,720 Cr	3,976,493 ↓ -50,000
Billionbrains Garage Ventures Ltd (Financial Services) Equity, Since 31 Jan 26 \| GROWW	5%	₹1,710 Cr	84,616,660
Shriram Finance Ltd (Financial Services) Equity, Since 31 Jan 26 \| SHRIRAMFIN	4%	₹1,416 Cr	13,590,867 ↑ 1,116,515
BSE Ltd (Financial Services) Equity, Since 30 Nov 25 \| BSE	4%	₹1,353 Cr	3,500,830

4. SBI Healthcare Opportunities Fund

(Erstwhile SBI Pharma Fund)

To provide the investors maximum growth opportunity through equity investments in stocks of growth oriented sectors of the economy.

Research Highlights for SBI Healthcare Opportunities Fund

Lower mid AUM (₹5,400 Cr).
Oldest track record among peers (21 yrs).
Rating: 2★ (bottom quartile).
Risk profile: High.
5Y return: 18.09% (lower mid).
3Y return: 23.64% (upper mid).
1Y return: 22.36% (lower mid).
Alpha: 3.75 (upper mid).
Sharpe: 0.71 (upper mid).
Information ratio: 0.02 (lower mid).
Higher exposure to Health Care vs peer median.
Top bond sector: Cash Equivalent.
Equity-heavy allocation (~97%).
High-quality debt (AAA/AA ~100%).
Largest holding Sun Pharmaceuticals Industries Ltd (~11.2%).

Below is the key information for SBI Healthcare Opportunities Fund

SBI Healthcare Opportunities Fund Growth
Launch Date	31 Dec 04
NAV (28 Aug 26)	₹523.677 ↑ 0.40 (0.08 %)
Net Assets (Cr)	₹5,400 on 31 Jul 26
Category	Equity - Sectoral
AMC	SBI Funds Management Private Limited
Rating	☆☆
Risk	High
Expense Ratio	1.97
Sharpe Ratio	0.71
Information Ratio	0.02
Alpha Ratio	3.75
Min Investment	5,000
Min SIP Investment	500
Exit Load	0-15 Days (0.5%),15 Days and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
31 Jul 21	₹10,000
31 Jul 22	₹8,982
31 Jul 23	₹11,731
31 Jul 24	₹16,334
31 Jul 25	₹18,834
31 Jul 26	₹21,900

SBI Healthcare Opportunities Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹481,656.
Net Profit of ₹181,656 Invest Now

Returns for SBI Healthcare Opportunities Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 27 Aug 26

Duration	Returns
1 Month	3.5%
3 Month	13.1%
6 Month	21.4%
1 Year	22.4%
3 Year	23.6%
5 Year	18.1%
10 Year
15 Year
Since launch	15.7%

Historical performance (Yearly) on absolute basis

Year	Returns
2025	-3.5%
2024	42.2%
2023	38.2%
2022	-6%
2021	20.1%
2020	65.8%
2019	-0.5%
2018	-9.9%
2017	2.1%
2016	-14%

Fund Manager information for SBI Healthcare Opportunities Fund

Name	Since	Tenure
Tanmaya Desai	1 Jun 11	15.18 Yr.

Data below for SBI Healthcare Opportunities Fund as on 31 Jul 26

Equity Sector Allocation

Sector	Value
Health Care	88.1%
Basic Materials	9.07%

Asset Allocation

Asset Class	Value
Cash	2.77%
Equity	97.17%
Debt	0.06%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
Sun Pharmaceuticals Industries Ltd (Healthcare) Equity, Since 31 Dec 17 \| SUNPHARMA	11%	₹559 Cr	3,000,000 ↑ 200,000
Acutaas Chemicals Ltd (Basic Materials) Equity, Since 30 Jun 24 \| 543349	6%	₹317 Cr	900,000
Divi's Laboratories Ltd (Healthcare) Equity, Since 31 Mar 12 \| DIVISLAB	6%	₹296 Cr	450,000
Apollo Hospitals Enterprise Ltd (Healthcare) Equity, Since 31 Jan 26 \| APOLLOHOSP	5%	₹260 Cr	300,000
Max Healthcare Institute Ltd Ordinary Shares (Healthcare) Equity, Since 31 Mar 21 \| MAXHEALTH	5%	₹254 Cr	2,250,000
Aurobindo Pharma Ltd (Healthcare) Equity, Since 31 Mar 26 \| AUROPHARMA	4%	₹208 Cr	1,320,000 ↑ 70,000
Aster DM Healthcare Ltd Ordinary Shares (Healthcare) Equity, Since 31 Mar 24 \| ASTERDM	4%	₹188 Cr	2,400,000
Laurus Labs Ltd (Healthcare) Equity, Since 31 Aug 23 \| 540222	4%	₹182 Cr	1,200,000
Cipla Ltd (Healthcare) Equity, Since 31 May 26 \| 500087	4%	₹176 Cr	1,200,000 ↑ 600,000
Torrent Pharmaceuticals Ltd (Healthcare) Equity, Since 30 Jun 21 \| TORNTPHARM	3%	₹166 Cr	360,000

5. Motilal Oswal Multicap 35 Fund

(Erstwhile Motilal Oswal MOSt Focused Multicap 35 Fund)

The investment objective of the Scheme is to achieve long term capital appreciation by primarily investing in a maximum of 35 equity & equity related instruments across sectors and market-capitalization levels.However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved.

Research Highlights for Motilal Oswal Multicap 35 Fund

Upper mid AUM (₹13,940 Cr).
Established history (12+ yrs).
Top rated.
Risk profile: Moderately High.
5Y return: 13.01% (bottom quartile).
3Y return: 20.49% (bottom quartile).
1Y return: 6.17% (bottom quartile).
Alpha: -3.79 (bottom quartile).
Sharpe: -0.26 (bottom quartile).
Information ratio: 0.70 (top quartile).
Higher exposure to Industrials vs peer median.
Top bond sector: Cash Equivalent.
Equity-heavy allocation (~98%).
Largest holding CG Power & Industrial Solutions Ltd (~6.7%).

Below is the key information for Motilal Oswal Multicap 35 Fund

Motilal Oswal Multicap 35 Fund Growth
Launch Date	28 Apr 14
NAV (28 Aug 26)	₹64.8453 ↑ 0.47 (0.74 %)
Net Assets (Cr)	₹13,940 on 31 Jul 26
Category	Equity - Multi Cap
AMC	Motilal Oswal Asset Management Co. Ltd
Rating	☆☆☆☆☆
Risk	Moderately High
Expense Ratio	1.77
Sharpe Ratio	-0.26
Information Ratio	0.7
Alpha Ratio	-3.79
Min Investment	5,000
Min SIP Investment	500
Exit Load	0-1 Years (1%),1 Years and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
31 Jul 21	₹10,000
31 Jul 22	₹9,336
31 Jul 23	₹10,720
31 Jul 24	₹16,877
31 Jul 25	₹18,011
31 Jul 26	₹17,952

Motilal Oswal Multicap 35 Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹426,080.
Net Profit of ₹126,080 Invest Now

Returns for Motilal Oswal Multicap 35 Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 27 Aug 26

Duration	Returns
1 Month	7.5%
3 Month	13.1%
6 Month	15.1%
1 Year	6.2%
3 Year	20.5%
5 Year	13%
10 Year
15 Year
Since launch	16.4%

Historical performance (Yearly) on absolute basis

Year	Returns
2025	-5.6%
2024	45.7%
2023	31%
2022	-3%
2021	15.3%
2020	10.3%
2019	7.9%
2018	-7.8%
2017	43.1%
2016	8.5%

Fund Manager information for Motilal Oswal Multicap 35 Fund

Name	Since	Tenure
Varun Sharma	21 Jan 26	0.53 Yr.
Swapnil Mayekar	18 Nov 25	0.7 Yr.
Ajay Khandelwal	1 Oct 24	1.83 Yr.
Ankit Agarwal	21 Jan 26	0.53 Yr.
Rakesh Shetty	22 Nov 22	3.69 Yr.

Data below for Motilal Oswal Multicap 35 Fund as on 31 Jul 26

Equity Sector Allocation

Sector	Value
Industrials	28.39%
Consumer Cyclical	22.36%
Financial Services	21.79%
Technology	18.16%
Health Care	6.17%
Basic Materials	1.39%

Asset Allocation

Asset Class	Value
Cash	1.74%
Equity	98.26%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
CG Power & Industrial Solutions Ltd (Industrials) Equity, Since 31 Jan 25 \| 500093	7%	₹885 Cr	9,300,000
Kalyan Jewellers India Ltd (Consumer Cyclical) Equity, Since 30 Sep 23 \| KALYANKJIL	7%	₹881 Cr	22,782,390
Eternal Ltd (Consumer Cyclical) Equity, Since 31 May 25 \| ETERNAL	5%	₹728 Cr	27,500,000
Coforge Ltd (Technology) Equity, Since 31 May 23 \| COFORGE	5%	₹628 Cr	4,285,614 ↓ -129,952
Shriram Finance Ltd (Financial Services) Equity, Since 31 Mar 26 \| SHRIRAMFIN	4%	₹587 Cr	5,630,608
Ather Energy Ltd (Consumer Cyclical) Equity, Since 28 Feb 26 \| ATHERENERG	4%	₹571 Cr	5,002,599 ↓ -200,000
Waaree Energies Ltd (Technology) Equity, Since 28 Feb 26 \| WAAREEENER	4%	₹501 Cr	1,700,905
IndusInd Bank Ltd (Financial Services) Equity, Since 28 Feb 26 \| INDUSINDBK	4%	₹477 Cr	5,165,661 ↑ 134,988
Samvardhana Motherson International Ltd (Consumer Cyclical) Equity, Since 30 Apr 26 \| MOTHERSON	4%	₹467 Cr	31,527,172
Apollo Hospitals Enterprise Ltd (Healthcare) Equity, Since 28 Feb 26 \| APOLLOHOSP	3%	₹439 Cr	506,046

6 മാസത്തെ മികച്ച 5 മ്യൂച്വൽ ഫണ്ടുകൾ

മൊത്തം ആസ്തിയുള്ള മികച്ച മ്യൂച്വൽ ഫണ്ടുകളുടെ ലിസ്റ്റ് ചുവടെയുണ്ട്100 കോടി കൂടാതെ കഴിഞ്ഞ 6 മാസങ്ങളിൽ മികച്ച വരുമാനം നൽകി.

1. Motilal Oswal Focused 25 Fund

(Erstwhile Motilal Oswal MOSt Focused 25 Fund)

Research Highlights for Motilal Oswal Focused 25 Fund

Lower mid AUM (₹1,693 Cr).
Established history (13+ yrs).
Rating: 3★ (upper mid).
Risk profile: Moderately High.
5Y return: 10.38% (bottom quartile).
3Y return: 14.39% (bottom quartile).
1Y return: 29.45% (top quartile).
Alpha: 12.26 (top quartile).
Sharpe: 0.61 (upper mid).
Information ratio: -0.07 (bottom quartile).
Higher exposure to Financial Services vs peer median.
Top bond sector: Cash Equivalent.
Equity-heavy allocation (~94%).
Largest holding Rubicon Research Ltd (~4.4%).

Below is the key information for Motilal Oswal Focused 25 Fund

Motilal Oswal Focused 25 Fund Growth
Launch Date	7 May 13
NAV (28 Aug 26)	₹53.8804 ↑ 0.21 (0.40 %)
Net Assets (Cr)	₹1,693 on 31 Jul 26
Category	Equity - Focused
AMC	Motilal Oswal Asset Management Co. Ltd
Rating	☆☆☆
Risk	Moderately High
Expense Ratio	1.97
Sharpe Ratio	0.61
Information Ratio	-0.07
Alpha Ratio	12.26
Min Investment	5,000
Min SIP Investment	500
Exit Load	0-1 Years (1%),1 Years and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
31 Jul 21	₹10,000
31 Jul 22	₹10,120
31 Jul 23	₹11,523
31 Jul 24	₹15,422
31 Jul 25	₹13,725
31 Jul 26	₹15,997

Motilal Oswal Focused 25 Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹395,578.
Net Profit of ₹95,578 Invest Now

Returns for Motilal Oswal Focused 25 Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 28 Aug 26

Duration	Returns
1 Month	9.7%
3 Month	15.9%
6 Month	25.4%
1 Year	29.4%
3 Year	14.4%
5 Year	10.4%
10 Year
15 Year
Since launch	13.5%

Historical performance (Yearly) on absolute basis

Year	Returns
2025	-1.7%
2024	13.6%
2023	18.8%
2022	2%
2021	14.6%
2020	17.3%
2019	17.1%
2018	-4.2%
2017	32.2%
2016	2.8%

Fund Manager information for Motilal Oswal Focused 25 Fund

Name	Since	Tenure
Varun Sharma	14 Aug 25	0.96 Yr.
Swapnil Mayekar	18 Nov 25	0.7 Yr.
Ankit Agarwal	5 Aug 25	0.99 Yr.
Rakesh Shetty	22 Nov 22	3.69 Yr.
Atul Mehra	1 Oct 24	1.83 Yr.

Data below for Motilal Oswal Focused 25 Fund as on 31 Jul 26

Equity Sector Allocation

Sector	Value
Financial Services	24.62%
Industrials	23.13%
Consumer Cyclical	18.96%
Health Care	8.46%
Technology	7.86%
Communication Services	3.06%
Utility	2.93%
Basic Materials	2.66%

Asset Allocation

Asset Class	Value
Cash	6.44%
Equity	93.56%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
Rubicon Research Ltd (Healthcare) Equity, Since 30 Apr 26 \| RUBICON	4%	₹73 Cr	518,073 ↑ 13,036
AU Small Finance Bank Ltd (Financial Services) Equity, Since 31 Oct 25 \| 540611	4%	₹69 Cr	669,589 ↑ 23,881
Eternal Ltd (Consumer Cyclical) Equity, Since 31 Jan 26 \| ETERNAL	4%	₹69 Cr	2,592,637 ↑ 62,681
CG Power & Industrial Solutions Ltd (Industrials) Equity, Since 28 Feb 26 \| 500093	4%	₹67 Cr	707,583
Aditya Infotech Ltd (Industrials) Equity, Since 28 Feb 26 \| CPPLUS	4%	₹66 Cr	181,175 ↓ -80,000
ICICI Prudential Asset Management Co Ltd (Financial Services) Equity, Since 31 Jan 26 \| ICICIAMC	4%	₹66 Cr	197,893 ↑ 4,703
Apollo Hospitals Enterprise Ltd (Healthcare) Equity, Since 28 Feb 26 \| APOLLOHOSP	4%	₹66 Cr	75,565
PNB Housing Finance Ltd (Financial Services) Equity, Since 31 May 26 \| PNBHOUSING	4%	₹57 Cr	553,533 ↑ 70,874
Titan Co Ltd (Consumer Cyclical) Equity, Since 31 Oct 25 \| TITAN	4%	₹57 Cr	130,247 ↑ 3,709
Gabriel India Ltd (Consumer Cyclical) Equity, Since 31 Aug 25 \| GABRIEL	3%	₹56 Cr	455,227 ↓ -81,000

2. IDBI Small Cap Fund

The Investment objective of the Scheme is to provide investors with the opportunities for long-term capital appreciation by investing predominantly in Equity and Equity related instruments of Small Cap companies. However there can be no assurance that the investment objective under the Scheme will be realized.

Research Highlights for IDBI Small Cap Fund

Bottom quartile AUM (₹758 Cr).
Established history (9+ yrs).
Not Rated.
Risk profile: Moderately High.
5Y return: 18.38% (top quartile).
3Y return: 18.85% (lower mid).
1Y return: 20.85% (bottom quartile).
Alpha: 4.12 (upper mid).
Sharpe: 0.26 (bottom quartile).
Information ratio: -0.07 (bottom quartile).
Top sector: Industrials.
Top bond sector: Cash Equivalent.
Equity-heavy allocation (~96%).
Largest holding Garware Hi-Tech Films Ltd (~4.9%).

Below is the key information for IDBI Small Cap Fund

IDBI Small Cap Fund Growth
Launch Date	21 Jun 17
NAV (28 Aug 26)	₹35.4771 ↑ 0.21 (0.60 %)
Net Assets (Cr)	₹758 on 31 Jul 26
Category	Equity - Small Cap
AMC	IDBI Asset Management Limited
Rating	Not Rated
Risk	Moderately High
Expense Ratio	2.3
Sharpe Ratio	0.26
Information Ratio	-0.07
Alpha Ratio	4.12
Min Investment	5,000
Min SIP Investment	500
Exit Load	0-12 Months (1%),12 Months and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
31 Jul 21	₹10,000
31 Jul 22	₹11,314
31 Jul 23	₹13,804
31 Jul 24	₹21,537
31 Jul 25	₹20,034
31 Jul 26	₹21,938

IDBI Small Cap Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹481,656.
Net Profit of ₹181,656 Invest Now

Returns for IDBI Small Cap Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 28 Aug 26

Duration	Returns
1 Month	7.6%
3 Month	11%
6 Month	24.9%
1 Year	20.9%
3 Year	18.9%
5 Year	18.4%
10 Year
15 Year
Since launch	14.8%

Historical performance (Yearly) on absolute basis

Year	Returns
2025	-13.4%
2024	40%
2023	33.4%
2022	2.4%
2021	64.7%
2020	19%
2019	-4.4%
2018	-15%
2017
2016

Fund Manager information for IDBI Small Cap Fund

Name	Since	Tenure
Dikshit Mittal	24 Jul 25	1.02 Yr.

Data below for IDBI Small Cap Fund as on 31 Jul 26

Equity Sector Allocation

Sector	Value
Industrials	23.79%
Consumer Cyclical	18.71%
Basic Materials	14.76%
Financial Services	12.22%
Consumer Defensive	9.96%
Technology	6.67%
Health Care	6.4%
Real Estate	1.43%
Utility	1.02%
Communication Services	0.89%

Asset Allocation

Asset Class	Value
Cash	4.17%
Equity	95.83%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
Garware Hi-Tech Films Ltd (Basic Materials) Equity, Since 30 Sep 25 \| 500655	5%	₹36 Cr	54,623 ↓ -3,838
Avalon Technologies Ltd (Technology) Equity, Since 31 Aug 23 \| AVALON	4%	₹29 Cr	162,956 ↓ -4,889
Manorama Industries Ltd (Consumer Defensive) Equity, Since 31 Dec 24 \| 541974	3%	₹24 Cr	142,461
Navin Fluorine International Ltd (Basic Materials) Equity, Since 30 Sep 19 \| NAVINFLUOR	3%	₹23 Cr	29,286
Allied Blenders and Distillers Ltd (Consumer Defensive) Equity, Since 31 Jul 24 \| ABDL	3%	₹22 Cr	326,615
Kirloskar Oil Engines Ltd (Industrials) Equity, Since 28 Feb 21 \| KIRLOSENG	3%	₹19 Cr	78,792
Schneider Electric Infrastructure Ltd (Industrials) Equity, Since 31 Aug 25 \| SCHNEIDER	2%	₹18 Cr	133,576
Arvind Fashions Ltd (Consumer Cyclical) Equity, Since 29 Feb 24 \| ARVINDFASN	2%	₹18 Cr	374,775 ↑ 13,091
KSH International Ltd (Industrials) Equity, Since 31 Dec 25 \| KSHINTL	2%	₹17 Cr	201,146 ↓ -32,069
Tata Motors Passenger Vehicles Ltd (Consumer Cyclical) Equity, Since 31 May 26 \| TMPV	2%	₹14 Cr	408,034 ↑ 200,288

3. SBI Healthcare Opportunities Fund

(Erstwhile SBI Pharma Fund)

To provide the investors maximum growth opportunity through equity investments in stocks of growth oriented sectors of the economy.

Research Highlights for SBI Healthcare Opportunities Fund

Upper mid AUM (₹5,400 Cr).
Established history (21+ yrs).
Rating: 2★ (lower mid).
Risk profile: High.
5Y return: 18.09% (upper mid).
3Y return: 23.64% (upper mid).
1Y return: 22.36% (lower mid).
Alpha: 3.75 (lower mid).
Sharpe: 0.71 (top quartile).
Information ratio: 0.02 (upper mid).
Higher exposure to Health Care vs peer median.
Top bond sector: Cash Equivalent.
Equity-heavy allocation (~97%).
High-quality debt (AAA/AA ~100%).
Largest holding Sun Pharmaceuticals Industries Ltd (~11.2%).

Below is the key information for SBI Healthcare Opportunities Fund

SBI Healthcare Opportunities Fund Growth
Launch Date	31 Dec 04
NAV (28 Aug 26)	₹523.677 ↑ 0.40 (0.08 %)
Net Assets (Cr)	₹5,400 on 31 Jul 26
Category	Equity - Sectoral
AMC	SBI Funds Management Private Limited
Rating	☆☆
Risk	High
Expense Ratio	1.97
Sharpe Ratio	0.71
Information Ratio	0.02
Alpha Ratio	3.75
Min Investment	5,000
Min SIP Investment	500
Exit Load	0-15 Days (0.5%),15 Days and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
31 Jul 21	₹10,000
31 Jul 22	₹8,982
31 Jul 23	₹11,731
31 Jul 24	₹16,334
31 Jul 25	₹18,834
31 Jul 26	₹21,900

SBI Healthcare Opportunities Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹481,656.
Net Profit of ₹181,656 Invest Now

Returns for SBI Healthcare Opportunities Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 28 Aug 26

Duration	Returns
1 Month	3.5%
3 Month	13.1%
6 Month	21.4%
1 Year	22.4%
3 Year	23.6%
5 Year	18.1%
10 Year
15 Year
Since launch	15.7%

Historical performance (Yearly) on absolute basis

Year	Returns
2025	-3.5%
2024	42.2%
2023	38.2%
2022	-6%
2021	20.1%
2020	65.8%
2019	-0.5%
2018	-9.9%
2017	2.1%
2016	-14%

Fund Manager information for SBI Healthcare Opportunities Fund

Name	Since	Tenure
Tanmaya Desai	1 Jun 11	15.18 Yr.

Data below for SBI Healthcare Opportunities Fund as on 31 Jul 26

Equity Sector Allocation

Sector	Value
Health Care	88.1%
Basic Materials	9.07%

Asset Allocation

Asset Class	Value
Cash	2.77%
Equity	97.17%
Debt	0.06%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
Sun Pharmaceuticals Industries Ltd (Healthcare) Equity, Since 31 Dec 17 \| SUNPHARMA	11%	₹559 Cr	3,000,000 ↑ 200,000
Acutaas Chemicals Ltd (Basic Materials) Equity, Since 30 Jun 24 \| 543349	6%	₹317 Cr	900,000
Divi's Laboratories Ltd (Healthcare) Equity, Since 31 Mar 12 \| DIVISLAB	6%	₹296 Cr	450,000
Apollo Hospitals Enterprise Ltd (Healthcare) Equity, Since 31 Jan 26 \| APOLLOHOSP	5%	₹260 Cr	300,000
Max Healthcare Institute Ltd Ordinary Shares (Healthcare) Equity, Since 31 Mar 21 \| MAXHEALTH	5%	₹254 Cr	2,250,000
Aurobindo Pharma Ltd (Healthcare) Equity, Since 31 Mar 26 \| AUROPHARMA	4%	₹208 Cr	1,320,000 ↑ 70,000
Aster DM Healthcare Ltd Ordinary Shares (Healthcare) Equity, Since 31 Mar 24 \| ASTERDM	4%	₹188 Cr	2,400,000
Laurus Labs Ltd (Healthcare) Equity, Since 31 Aug 23 \| 540222	4%	₹182 Cr	1,200,000
Cipla Ltd (Healthcare) Equity, Since 31 May 26 \| 500087	4%	₹176 Cr	1,200,000 ↑ 600,000
Torrent Pharmaceuticals Ltd (Healthcare) Equity, Since 30 Jun 21 \| TORNTPHARM	3%	₹166 Cr	360,000

4. Aditya Birla Sun Life Small Cap Fund

(Erstwhile Aditya Birla Sun Life Small & Midcap Fund)

An Open ended Small and Mid Cap Equity Scheme with an objective to generate consistent long-term capital appreciation by investing predominantly in equity and equity related securities of companies considered to be small and midcap. The Scheme may also invest a certain portion of its corpus in fixed income securities including money market instruments, in order to meet liquidity requirements from time to time.

Research Highlights for Aditya Birla Sun Life Small Cap Fund

Highest AUM (₹5,865 Cr).
Established history (19+ yrs).
Top rated.
Risk profile: Moderately High.
5Y return: 14.65% (bottom quartile).
3Y return: 16.25% (bottom quartile).
1Y return: 23.19% (upper mid).
Alpha: 0.00 (bottom quartile).
Sharpe: 0.40 (bottom quartile).
Information ratio: 0.00 (lower mid).
Top sector: Financial Services.
Top bond sector: Cash Equivalent.
Equity-heavy allocation (~96%).
Largest holding Sai Life Sciences Ltd (~2.8%).

Below is the key information for Aditya Birla Sun Life Small Cap Fund

Aditya Birla Sun Life Small Cap Fund Growth
Launch Date	31 May 07
NAV (28 Aug 26)	₹101.727 ↑ 0.53 (0.52 %)
Net Assets (Cr)	₹5,865 on 31 Jul 26
Category	Equity - Small Cap
AMC	Birla Sun Life Asset Management Co Ltd
Rating	☆☆☆☆☆
Risk	Moderately High
Expense Ratio	1.89
Sharpe Ratio	0.4
Information Ratio	0
Alpha Ratio	0
Min Investment	1,000
Min SIP Investment	1,000
Exit Load	0-365 Days (1%),365 Days and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
31 Jul 21	₹10,000
31 Jul 22	₹9,333
31 Jul 23	₹11,775
31 Jul 24	₹16,843
31 Jul 25	₹15,923
31 Jul 26	₹17,962

Aditya Birla Sun Life Small Cap Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹436,710.
Net Profit of ₹136,710 Invest Now

Returns for Aditya Birla Sun Life Small Cap Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 28 Aug 26

Duration	Returns
1 Month	6.6%
3 Month	10.9%
6 Month	21.1%
1 Year	23.2%
3 Year	16.2%
5 Year	14.6%
10 Year
15 Year
Since launch	12.7%

Historical performance (Yearly) on absolute basis

Year	Returns
2025	-3.7%
2024	21.5%
2023	39.4%
2022	-6.5%
2021	51.4%
2020	19.8%
2019	-11.5%
2018	-22.6%
2017	56.7%
2016	9.7%

Fund Manager information for Aditya Birla Sun Life Small Cap Fund

Name	Since	Tenure
Abhinav Khandelwal	31 Oct 24	1.75 Yr.
Dhaval Joshi	21 Nov 22	3.7 Yr.

Data below for Aditya Birla Sun Life Small Cap Fund as on 31 Jul 26

Equity Sector Allocation

Sector	Value
Financial Services	19.23%
Consumer Cyclical	18.98%
Industrials	14.52%
Health Care	13.22%
Basic Materials	12.28%
Consumer Defensive	8.55%
Technology	3.4%
Real Estate	3.37%
Utility	1.45%
Communication Services	0.97%

Asset Allocation

Asset Class	Value
Cash	4.05%
Equity	95.95%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
Sai Life Sciences Ltd (Healthcare) Equity, Since 30 Jun 25 \| SAILIFE	3%	₹162 Cr	1,313,192 ↑ 26,527
Navin Fluorine International Ltd (Basic Materials) Equity, Since 31 Jul 20 \| NAVINFLUOR	3%	₹162 Cr	210,525 ↓ -19,475
Arvind Ltd (Consumer Cyclical) Equity, Since 30 Nov 24 \| 500101	3%	₹148 Cr	2,526,165 ↓ -200,000
TD Power Systems Ltd (Industrials) Equity, Since 30 Jun 23 \| TDPOWERSYS	2%	₹136 Cr	1,096,068
CCL Products (India) Ltd (Consumer Defensive) Equity, Since 31 May 20 \| CCL	2%	₹125 Cr	1,060,480
Radico Khaitan Ltd (Consumer Defensive) Equity, Since 31 May 20 \| RADICO	2%	₹119 Cr	302,373 ↓ -25,000
Bikaji Foods International Ltd (Consumer Defensive) Equity, Since 30 Nov 22 \| BIKAJI	2%	₹117 Cr	1,802,177 ↑ 233,999
PNB Housing Finance Ltd (Financial Services) Equity, Since 31 Aug 24 \| PNBHOUSING	2%	₹112 Cr	1,081,130
Ujjivan Small Finance Bank Ltd Ordinary Shares (Financial Services) Equity, Since 31 Mar 25 \| UJJIVANSFB	2%	₹112 Cr	18,907,129
Shaily Engineering Plastics Ltd (Basic Materials) Equity, Since 31 Oct 25 \| 501423	2%	₹109 Cr	376,964 ↑ 15,952

5. UTI Healthcare Fund

(Erstwhile UTI Pharma & Healthcare Fund)

The Investment objective of the Scheme is capital appreciation through investments in equities and equity related instruments of the Pharma & Healthcare sectors.

Research Highlights for UTI Healthcare Fund

Bottom quartile AUM (₹1,371 Cr).
Oldest track record among peers (27 yrs).
Rating: 1★ (bottom quartile).
Risk profile: High.
5Y return: 15.57% (lower mid).
3Y return: 23.76% (top quartile).
1Y return: 18.54% (bottom quartile).
Alpha: 0.66 (bottom quartile).
Sharpe: 0.51 (lower mid).
Information ratio: 0.05 (top quartile).
Higher exposure to Health Care vs peer median.
Top bond sector: Cash Equivalent.
Equity-heavy allocation (~95%).
Largest holding Sun Pharmaceuticals Industries Ltd (~8.5%).

Below is the key information for UTI Healthcare Fund

UTI Healthcare Fund Growth
Launch Date	28 Jun 99
NAV (28 Aug 26)	₹342.939 ↑ 0.55 (0.16 %)
Net Assets (Cr)	₹1,371 on 31 Jul 26
Category	Equity - Sectoral
AMC	UTI Asset Management Company Ltd
Rating	☆
Risk	High
Expense Ratio	2.26
Sharpe Ratio	0.51
Information Ratio	0.05
Alpha Ratio	0.66
Min Investment	5,000
Min SIP Investment	500
Exit Load	0-1 Years (1%),1 Years and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
31 Jul 21	₹10,000
31 Jul 22	₹8,749
31 Jul 23	₹10,615
31 Jul 24	₹15,542
31 Jul 25	₹17,610
31 Jul 26	₹19,855

UTI Healthcare Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹447,579.
Net Profit of ₹147,579 Invest Now

Returns for UTI Healthcare Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 28 Aug 26

Duration	Returns
1 Month	3.7%
3 Month	10.7%
6 Month	20.4%
1 Year	18.5%
3 Year	23.8%
5 Year	15.6%
10 Year
15 Year
Since launch	15.1%

Historical performance (Yearly) on absolute basis

Year	Returns
2025	-3.1%
2024	42.9%
2023	38.2%
2022	-12.3%
2021	19.1%
2020	67.4%
2019	1.2%
2018	-7.5%
2017	6.2%
2016	-9.7%

Fund Manager information for UTI Healthcare Fund

Name	Since	Tenure
Kamal Gada	2 May 22	4.25 Yr.

Data below for UTI Healthcare Fund as on 31 Jul 26

Equity Sector Allocation

Sector	Value
Health Care	95.05%

Asset Allocation

Asset Class	Value
Cash	4.95%
Equity	95.05%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
Sun Pharmaceuticals Industries Ltd (Healthcare) Equity, Since 31 Oct 06 \| SUNPHARMA	9%	₹112 Cr	600,000
Ajanta Pharma Ltd (Healthcare) Equity, Since 31 Jul 17 \| 532331	5%	₹66 Cr	194,021 ↓ -1,274
Divi's Laboratories Ltd (Healthcare) Equity, Since 30 Sep 17 \| DIVISLAB	5%	₹62 Cr	94,242 ↑ 5,428
Gland Pharma Ltd (Healthcare) Equity, Since 30 Nov 20 \| GLAND	4%	₹54 Cr	215,251
Caplin Point Laboratories Ltd (Healthcare) Equity, Since 31 Dec 23 \| CAPLIPOINT	4%	₹53 Cr	200,000 ↑ 15,000
Lupin Ltd (Healthcare) Equity, Since 28 Feb 25 \| 500257	4%	₹49 Cr	203,834
Apollo Hospitals Enterprise Ltd (Healthcare) Equity, Since 30 Apr 21 \| APOLLOHOSP	4%	₹46 Cr	53,000
Alkem Laboratories Ltd (Healthcare) Equity, Since 31 May 21 \| ALKEM	3%	₹41 Cr	73,830 ↑ 5,830
Dr Reddy's Laboratories Ltd (Healthcare) Equity, Since 28 Feb 18 \| DRREDDY	3%	₹39 Cr	290,000
Max Healthcare Institute Ltd Ordinary Shares (Healthcare) Equity, Since 31 Mar 24 \| MAXHEALTH	3%	₹39 Cr	344,969

മ്യൂച്വൽ ഫണ്ടുകളിൽ ഓൺലൈനിൽ എങ്ങനെ നിക്ഷേപിക്കാം?

Fincash.com-ൽ ആജീവനാന്ത സൗജന്യ നിക്ഷേപ അക്കൗണ്ട് തുറക്കുക.

നിങ്ങളുടെ രജിസ്ട്രേഷനും KYC പ്രക്രിയയും പൂർത്തിയാക്കുക

രേഖകൾ അപ്‌ലോഡ് ചെയ്യുക (പാൻ, ആധാർ മുതലായവ).കൂടാതെ, നിങ്ങൾ നിക്ഷേപിക്കാൻ തയ്യാറാണ്!

തുടങ്ങി

Disclaimer:
ഇവിടെ നൽകിയിരിക്കുന്ന വിവരങ്ങൾ കൃത്യമാണെന്ന് ഉറപ്പാക്കാൻ എല്ലാ ശ്രമങ്ങളും നടത്തിയിട്ടുണ്ട്. എന്നിരുന്നാലും, ഡാറ്റയുടെ കൃത്യത സംബന്ധിച്ച് യാതൊരു ഉറപ്പും നൽകുന്നില്ല. എന്തെങ്കിലും നിക്ഷേപം നടത്തുന്നതിന് മുമ്പ് സ്കീം വിവര രേഖ ഉപയോഗിച്ച് പരിശോധിക്കുക.